Key Oncologics (Pty) Ltd is a South African pharmaceutical company that focuses on haematology/oncology, orphan/niche market therapies, and Section 21 Name Patient Programs.

The company was founded in 1998 representing international companies that do not have an independent presence in South Africa.

Key Oncologics (Pty) Ltd continues to seek options for patients to live longer and live better.

Our purpose as a company is to serve the public health by:
Delivering innovative products to improve patient outcome through partnering with companies that compliment our mission
Helping patients navigate the challenges of medical aid coverage to ensure they have access to the medicines they need
Providing outstanding customer service
Integration of scientific and commercial knowledge
Employing competent and qualified people
Supporting and maintaining excellent relationships with stakeholders in the therapeutic areas we serve